<DOC>
	<DOCNO>NCT00038935</DOCNO>
	<brief_summary>The purpose study determine relative bioavailability ReFacto AF compare ReFacto , administer 2-minute bolus infusion .</brief_summary>
	<brief_title>Study Evaluating BDDRFVIII ReFacto AF Hemophilia A</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Severe hemophilia A ( FVIII : C &lt; 1 % local laboratory ) Previously treat patient ( PTP ) least 250 exposure day factor VIII product Age great equal 12 years\ The presence bleed disorder addition hemophilia A Concomitant therapy immunosuppressant drug ( e.g. , intravenous immunoglobulin ( IVIG ) , routine systemic corticosteroid use ) History detectable factor VIII inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Hemophilia</keyword>
</DOC>